<?xml version="1.0" encoding="UTF-8"?>
<ref id="B265-marinedrugs-18-00627">
 <label>265.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Aissaoui</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Abidi</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Hardouin</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Abdelkafi</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Marrakchi</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Jouenne</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Marzouki</surname>
    <given-names>M.N.</given-names>
   </name>
  </person-group>
  <article-title>ACE Inhibitory and Antioxidant Activities of Novel Peptides from Scorpaena Notata By-Product Protein Hydrolysate</article-title>
  <source>Int. J. Pept. Res. Ther.</source>
  <year>2017</year>
  <volume>23</volume>
  <fpage>13</fpage>
  <lpage>23</lpage>
  <pub-id pub-id-type="doi">10.1007/s10989-016-9536-6</pub-id>
 </element-citation>
</ref>
